Collectively, these results suggested that PRMT5 regulated proliferation via the Wnt4/β-catenin axis in laryngeal carcinoma, and the PRMT5/Wnt4 axis may serve as a potential therapeutic target for laryngeal carcinoma. This evidence concerns the gene WNT4 and laryngeal carcinoma.